Company intelligence / Profile preview

NMX Research and Solutions

Ownership: Private
Employees: ~19
Development stage: Other

Overview

NMX Research and Solutions is a contract research organization specializing in advanced biophysics platforms—particularly nuclear magnetic resonance (NMR)-based fragment screening—to accelerate early-stage small-molecule drug discovery. They offer proprietary workflows for hit identification, binding characterization, and protein-ligand interaction studies. Their clients include pharmaceutical and biotech companies seeking to boost preclinical pipeline productivity through innovative screening technologies.

Modalities: Small moleculeFragment-based drug discoveryBiologic (for protein production services)
Industry: Drug Discovery Services

Partnerships

Engages in strategic partnerships with both academia and industry to enhance drug-discovery programs. Specific partners are not publicly listed.

Beyond the preview

Go deeper on NMX Research and Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NMX Research and Solutions.

Explore the full profile